Cosentyx® HS Secukinumab 300 mg - Reimbursement form initiation (Dutch)
Download Dutch document
Cosentyx® HS Secukinumab 300 mg - Reimbursement form prolongation (Dutch)
Download Dutch documentCosentyx® HS Secukinumab 300 mg - Reimbursement form prolongation (French)
Download French documentCosentyx® HS Secukinumab 300 mg - Reimbursement form initiation (French)
Download French documentReimbursement / E-health - Kesimpta
Kesimpta ® is reimbursed in Belgium for adult patients with clinically proven relapsing multiple sclerosis (RMS) who meet the following criteria* :
The patient has a fast evolving, serious form of relapsing multiple sclerosis (RMS...
Twitter Linkedin Facebook Pinterest Google plusPatient Resources
Ilaris - FMF patient brochure Armenian
Patient brochure | Familial Mediterranean Fever (FMF) - ARMENIAN Download Armenian documentIlaris - FMF patient brochure Turkish
Patient brochure | Familial Mediterranean Fever (FMF) - TURKISH Download Turkish documentIlaris - FMF patient brochure English
Patient brochure | Familial Mediterranean Fever (FMF) - ENGLISH Download documentIlaris - FMF patient brochure Dutch
Patient brochure | Familial Mediterranean Fever (FMF) - DUTCH Download Dutch document
×